Velocity Clinical Research

The trials here

What the 10 trials at this site are about, from their registry records.

Conditions

• Obesity5 trials
• Type 2 diabetes5 trials
• Type 1 diabetes2 trials
• Fatty liver disease (MASLD/MASH)1 trial

Phase

• Phase 26 trials
• Phase 11 trial
• Phase 1/21 trial
• Phase 31 trial

Status

• Completed9 trials
• Recruiting1 trial

Lead sponsor

• Hoffmann-La Roche3 trials
• Biomea Fusion Inc.2 trials
• Regor Pharmaceuticals Inc.2 trials
• Corbus Pharmaceuticals Inc.1 trial
• Ionis Pharmaceuticals, Inc.1 trial
• and 1 more

Running trials

• Recruiting

  A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes

  NCT07351058· Phase 3· Hoffmann-La Roche· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Obesity1 recruiting
• Type 2 diabetes1 recruiting

Closed trials

• Completed

  A 2-part, Phase 1b Clinical Study Designed to Evaluate the Safety, PK, and Efficacy of CRB-913 in Participants With Obesity

  NCT07310901· Phase 1· Corbus Pharmaceuticals Inc.· Source

• Recruiting

  A Study to Compare Different Doses of Tifeglipron (RO7795081) With Placebo or Semaglutide in People With Type 2 Diabetes

  NCT07112872· Phase 2· Hoffmann-La Roche· Source

• Completed

  A Study Evaluating the Effect of Daily Oral Tifeglipron (RO7795081) in Participants With Obesity or Overweight With at Least One Weight-Related Comorbidity

  NCT07081958· Phase 2· Hoffmann-La Roche· Source

• Completed

  Study of Once-Daily Oral RGT001-075 Compared With Placebo in Adults With Obesity or Are Overweight With Weight-Related Health Conditions

  NCT06867718· Phase 2· Regor Pharmaceuticals Inc.· Source

• Completed

  A Study of RGT001-075 in Participants With Obesity or Overweight With Weight-Related Comorbidities

  NCT06277934· Phase 2· Regor Pharmaceuticals Inc.· Source

• Completed

  Phase 2 Trial of BMF-219 in Participants With Type 1 Diabetes Mellitus

  NCT06152042· Phase 2· Biomea Fusion Inc.· Source

• Completed

  Study of BMF-219 in Healthy Adult Subjects and in Adult Subjects With Type 2 Diabetes Mellitus (T2D)

  NCT05731544· Phase 1/2· Biomea Fusion Inc.· Source

• Completed

  In-Home Study With MiniMed™ 780G Pump Automated Control in Type 2-Evaluation of the AHCL System in Adults With Insulin-requiring Type 2 Diabetes

  NCT05238142· Medtronic MiniMed, Inc.· Source

• Completed

  A Study to Assess the Safety, Efficacy, and Pharmacokinetics of Multiple Doses of ION224

  NCT04932512· Phase 2· Ionis Pharmaceuticals, Inc.· Source